Search

Researchers at Johns Hopkins University have developed a Gold Nanoprism Enhanced SERS Aptasensor for the simultaneous detection of thrombin and VEGF. This innovative approach utilizes aptamers for biomolecular sensing, offering high sensitivity and specificity. The study marks a significant advancement in developing aptamer-based spectroscopical tools for various applications in biology and medicine. The research was supported by the NIH National Institute of General Medical Sciences (NIGMS) and has been peer-reviewed. [Extracted from the article]

The article details a study from Tabriz University of Medical Sciences on a new method for detecting hyaluronic acid (HA) in human biofluids using triangular silver nanoprisms (TA-AgNPrs). Topics discussed include the innovative use of TA-AgNPrs for rapid and sensitive HA detection, the development of colorimetric setups for on-site analysis, and the potential applications for monitoring diseases associated with abnormal HA levels.

The article focuses on a study that developed two innovative nanoformulations combining chemotherapy and photothermal therapy for cancer treatment. Researchers utilized gold nanoprisms (AuNPRs), thermosensitive liposomes (TSLs), and silica nanoparticles (BioSiNPs) to create multifunctional systems capable of controlled drug delivery. It found that these nanoformulations effectively release hydrophilic drugs when triggered by near-infrared (NIR) laser, offering a precise cancer therapy.

Researchers from the National Research Council (CNR) in Pozzuoli, Italy, have been studying the use of plasmonic nanomaterials to remotely manipulate intracellular pathways in single cells. By using gold nanoprisms and near infrared irradiation, they were able to enhance tissue regeneration and stem cell activity in the small invertebrate Hydra vulgaris. The results suggest that heat emitting nanoparticles can control cell stemness and be targeted for regenerative medicine or wound healing strategies. This research has been peer-reviewed and published in Advanced Functional Materials. [Extracted from the article]

A recent study conducted by researchers at Third Military Medical University in Chongqing, China, has found that a combination of buformin and p65 siRNA-loaded DNA nanoprism can effectively alleviate acute lung injury (ALI) by inhibiting NLRP3-mediated pyroptosis. Pyroptosis is a form of cell death that leads to severe respiratory damage and cytokine storms. The DNA nanoprism acts as a drug delivery vehicle, delivering buformin and p65 siRNA to inhibit pyroptosis. This study suggests that this DNA nanoplatform has the potential to revolutionize the treatment of ALI by providing synergistic therapeutic effects. [Extracted from the article]

Researchers from Tabriz University of Medical Sciences in Iran have developed a new platform for the colorimetric quantification of malondialdehyde (MDA) using silver nanoprisms. MDA is a biomarker of oxidative stress and is associated with various diseases. The researchers synthesized different types of silver nanoparticles and used them for the chemosensing of MDA. They found that the silver nanoprisms showed high stability and great optical properties, making them suitable for the detection of MDA. The researchers believe that this innovative process could lead to the development of simple and effective on-site recognition devices for harmful substances or illegal drugs. [Extracted from the article]

For more information on this research see: Folic Acid Conjugated Cus Nanoprisms for Cancer Targeting and Photothermal Treatment. Keywords: Baghdad; Iraq; Asia; Cancer; Emerging Technologies; Folic Acid; Health and Medicine; Nanoprisms; Nanotechnology; Oncology; Pharmaceuticals EN Baghdad Iraq Asia Cancer Emerging Technologies Folic Acid Health and Medicine Nanoprisms Nanotechnology Oncology Pharmaceuticals 1384 1384 1 11/06/23 20231110 NES 231110 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on Cancer have been published. [Extracted from the article]

Keywords for this news article include: Budapest, Hungary, Europe, Cysteamine, Emerging Technologies, Health and Medicine, Nanoprisms, Nanosphere, Nanospheres, Nanotechnology, Center for Energy Research. Keywords: Budapest; Hungary; Europe; Cysteamine; Emerging Technologies; Health and Medicine; Nanoprisms; Nanosphere; Nanospheres; Nanotechnology EN Budapest Hungary Europe Cysteamine Emerging Technologies Health and Medicine Nanoprisms Nanosphere Nanospheres Nanotechnology 1336 1336 1 03/23/23 20230317 NES 230317 2023 MAR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in Nanotechnology - Nanoprisms. [Extracted from the article]